During the past decade, Providence Neurological Specialties conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Neurological Specialties" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Institute for Systems Biology" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Providence Neurological Specialties" are "Multiple Sclerosis" (5 trials), "Relapsing Multiple Sclerosis" (2 trials) and "Infusion Reaction" (1 trials). Many other conditions were trialed in "Providence Neurological Specialties" in a lesser frequency.

Most popular intervention types in "Providence Neurological Specialties" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "All patients in the study will be treated with ocrelizumab" (1 trials), "Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus" (1 trials), "Cladribine Tablets" (1 trials) and "Fenebrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Neurological Specialties" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Providence Neurological Specialties". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Providence Neurological Specialties, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Neurological Specialties, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".